Overview
Portfolio
More
Packvc
Seattle, United States
Invests in pre‑seed and seed stage founders connected to the University of Washington network, making venture capital accessible to UW alumni.
Portfolio
27+
Employees
15+
Founded
2021
AUM
≈ $30.0M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Fund details
Funds
Pack Ventures I
Vintage 2022
Pack Ventures II
Vintage 2024 • $30.0M
Sources
Packvc
Invests in pre‑seed and seed stage founders connected to the University of Washington network, making venture capital accessible to UW alumni.
Portfolio
27+
Employees
15+
Founded
2021
AUM
≈ $30.0M
Funds
Pack Ventures I · Vintage 2022
Pack Ventures II · Vintage 2024 • $30.0M
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 24 of 25 matched portfolio companies
The startup develops immune therapeutic treatments that deliver specific antigens to receptors on immune cells, enhancing protective immunity against cancer and chronic viral diseases. This platform allows healthcare professionals to utilize a versatile system that can be tailored with various cancer or viral antigens for targeted treatment.
This company provides aerial data acquisition and analysis services utilizing unmanned aerial systems (UAS). They capture high-resolution imagery and sensor data for detailed site mapping and inspection. The resulting deliverables support infrastructure monitoring, land surveying, and construction progress tracking.
Alongside provides a clinician-developed AI wellbeing coach to support K-12 students with stress, emotional challenges, and skill-building. This platform offers confidential, multilingual support through interactive chats and curated activities like mood tracking and journaling. The service aims to reduce student anxiety, improve focus, and boost school attendance rates for partner districts.
Archon Bio develops geometrically tunable protein therapeutics called Antibody Cages (AbCs) by integrating generative AI design with structural control. This platform enables precise engineering of biodistribution, engagement, and function to target previously intractable therapeutic pathways. The company transforms biologics into differentiated drugs by leveraging structural innovation to improve therapeutic effect.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
Cimba provides a self-service AI enablement platform allowing enterprise analysts to build custom, no-code AI agents. These agents automate routine workflows and partner on complex tasks to multiply team capacity and accelerate decision-making. The platform emphasizes transparent, auditable accuracy, enabling rapid deployment across finance, customer success, and operations intelligence domains.
Funding: $1.3M
Rough estimate of the amount of funding raised
Funding: $1.3M
Rough estimate of the amount of funding raised
CyclerATX is developing targeted protein degradation technology specifically for extracellular drivers of neuropsychiatric and neurodegenerative diseases. This approach aims to create effective protein degraders that can significantly enhance treatment outcomes for patients suffering from these conditions.
Enosemi develops photonics subsystems, including chipsets and custom silicon, to enhance optical circuit integration for various applications. Their silicon-verified IP blocks minimize design risks and accelerate time-to-market, allowing companies to focus on technology differentiation.
Funding: $150.0K
Rough estimate of the amount of funding raised
Funding: $150.0K
Rough estimate of the amount of funding raised
This company provides pre-payment claim review services for self-funded health plans and their members to ensure fair billing for hospital visits. They achieve savings by instantly screening for 501(r) discounts and using medical record data to flag overcharges before adjudication. The service maximizes savings for plans while reducing patient responsibility through comprehensive coding and clinical reviews.
Funding: $5.4M
Rough estimate of the amount of funding raised
Funding: $5.4M
Rough estimate of the amount of funding raised
Hearvana develops super-intelligent acoustic intelligence systems for both human and machine applications. The company focuses on unlocking advanced capabilities through sophisticated sound analysis and processing. This technology provides a new layer of actionable data derived from auditory environments.
Lila offers an AI‑driven protein design platform combined with a high‑throughput discovery pipeline to create therapeutic proteins with optimized affinity, selectivity, and pharmacokinetics. The system leverages chemically synthesizable scaffolds, unnatural amino acids, and proprietary linker‑payload technology to enable high‑dose subcutaneous delivery and targeted radiotherapy constructs for biopharma developers.
Olis® provides a video-based diagnostic system for industrial robots, utilizing a cabinet-mounted industrial PC and Power-over-Ethernet cameras to monitor and analyze robotic operations in real-time. This technology enables users to quickly identify the root causes of robot failures, enhancing operational efficiency and minimizing downtime through automated telemetry logs and fault event recordings.
Funding: $4.1M
Rough estimate of the amount of funding raised
Funding: $4.1M
Rough estimate of the amount of funding raised
Outbound AI provides a Conversation AI Cloud specifically engineered for healthcare revenue cycle operations. Their AI agents automate and streamline burdensome, phone-based administrative tasks like billing and claims processing. This technology augments existing staff productivity while accelerating time to payment for healthcare organizations.
Funding: $16.0M
Rough estimate of the amount of funding raised
Funding: $16.0M
Rough estimate of the amount of funding raised
Phase Genomics develops ultra-long-range genome sequencing technology and computational tools that enable the assembly of complete and accurate genomes and metagenomes without the need for cultivation. This platform addresses the challenge of obtaining high-resolution genomic data, facilitating breakthroughs in agriculture, human health, and industrial biology.
Funding: $5.8M
Rough estimate of the amount of funding raised
Funding: $5.8M
Rough estimate of the amount of funding raised
Proxi provides a no-code platform for creating and sharing interactive maps, allowing users to customize map content with unique colors, icons, and branding while enabling crowdsourced point additions. This technology addresses the need for businesses and individuals to easily visualize and share location-based information, enhancing engagement and collaboration within communities.
Funding: $1.2M
Rough estimate of the amount of funding raised
Funding: $1.2M
Rough estimate of the amount of funding raised
Rainfall Health utilizes artificial intelligence to enhance healthcare access in rural areas, connecting patients with a network of over 6,000 diverse providers. The platform addresses the lack of quality healthcare in medical deserts by facilitating tailored care solutions that meet the unique needs of underserved communities.
Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.
Funding: $186.0M
Rough estimate of the amount of funding raised
Funding: $186.0M
Rough estimate of the amount of funding raised
Solo is an analytical software platform that aggregates data from various gig economy applications to provide city-level pay benchmarks and hour-by-hour earnings predictions. The platform guarantees daily pay by compensating users if their earnings fall short of projected amounts, enabling gig workers to optimize their income and manage multiple job sources effectively.
Supio offers an agentic AI platform tailored for plaintiff and mass‑tort law firms that automates intake, medical record analysis, demand‑letter drafting, and litigation document creation while preserving full case context. The system captures firm‑wide institutional knowledge, provides continuous case‑signal monitoring for missed injuries, and integrates real‑time case economics, enabling firms to handle more cases and achieve higher‑value settlements without additional staffing.
Funding: $60.0M
Rough estimate of the amount of funding raised
Funding: $60.0M
Rough estimate of the amount of funding raised
Talus Bio provides a proprietary platform that quantifies and modulates the regulome—the network of regulatory proteins that control gene expression—directly in live cells using functional proteomics and high‑throughput assays. The system generates millions of compound‑target interaction data points and leverages AI to design chemical libraries that target transcription factors, cofactors, and splicing regulators, enabling pharmaceutical companies to discover and develop therapies against previously undruggable regulatory proteins.
Funding: $11.2M
Rough estimate of the amount of funding raised
Funding: $11.2M
Rough estimate of the amount of funding raised
Turion Space develops integrated hardware and software solutions for space infrastructure management and operations. They offer a unified software layer for fleet command, simulation, and data archiving for satellite operations. The company also provides configurable satellite platforms and advanced gridded ion propulsion systems to enhance in-orbit maneuverability and mission capability delivery.
Funding: $27.8M
Rough estimate of the amount of funding raised
Funding: $27.8M
Rough estimate of the amount of funding raised
Violett provides an air health platform that utilizes UVC Vortex technology and HEPA filtration for comprehensive air disinfection. This system actively destroys airborne pollutants including viruses, bacteria, mold, and allergens in indoor environments. The platform also integrates precision sensors to deliver real-time air quality monitoring and health intelligence to users.
Funding: $2.3M
Rough estimate of the amount of funding raised
Funding: $2.3M
Rough estimate of the amount of funding raised
WaveWorks develops hardware building blocks utilizing backscatter technology to significantly reduce power consumption, cost, and size for wireless communication. This technology enables devices to transmit data using up to 99.9% less power than conventional radios while maintaining standard protocol compatibility. The resulting low-power, small-footprint solutions are ideal for applications ranging from mobile peripherals and Industrial IoT to deeply embedded and aerospace systems.
Wokelo AI develops machine learning models to automate complex data processing tasks for enterprises. The platform specializes in natural language understanding and predictive analytics to extract actionable insights from unstructured datasets. This automation streamlines operational workflows and improves decision-making accuracy across various business functions.
Funding: $5.5M
Rough estimate of the amount of funding raised
Funding: $5.5M
Rough estimate of the amount of funding raised
Modulus develops engineered Natural Killer (NK) cell therapies optimized for autoimmune diseases, utilizing switch receptor arrays and best-in-class CARs to enhance safety and efficacy. The company addresses the limitations of existing CAR-T therapies, such as patient selection challenges and accessibility issues, by providing off-the-shelf solutions that eliminate the need for lymphodepletion.
Funding: $3.8M
Rough estimate of the amount of funding raised
Funding: $3.8M
Rough estimate of the amount of funding raised
Showing 2 of 2 unmatched portfolio companies